Batch-to-batch variability and low tablet production yields remain persistent challenges in solid dosage manufacturing. When inconsistencies arise, manufacturers often focus on excipient selection or process parameter adjustments. In many cases, the underlying issue is in the selection of the granulation process itself. This article explores Canaan’s granulation solutions for different material characteristics and process requirements, highlighting how the right process selection can improve granule quality and support more consistent downstream tableting operations.
Two common challenges in solid dosage manufacturing are significant quality variations between batches of the same product and low first-pass yield during tablet compression, resulting in increased rejects and rework.
The root causes can often be traced back to the granulation stage:
When these factors occur together, maintaining consistent tablet quality becomes considerably more difficult.
When process variations occur, manufacturers often start by modifying the formulation or adjusting operating parameters—for example, increasing binder concentration, changing compression force or modifying equipment speed.
While these adjustments may improve results in the short term, they do not necessarily address the underlying cause. The particle structure, bulk density and particle size distribution of the granules remain largely determined by the granulation process. If the selected process is not suited to the material characteristics, downstream variations may persist despite repeated adjustments.
In other words, formulation and parameter optimization can improve process performance, but the choice of granulation technology establishes the foundation for consistent manufacturing.
Canaan offers a range of granulation technologies designed to accommodate different material properties, product characteristics and production requirements. Selecting the appropriate process helps establish a more reliable foundation for downstream manufacturing.
1. General Products and High-Volume Production → Wet Granulation
Wet granulation is widely used in solid dosage manufacturing due to its broad applicability and suitability for large-scale production. It remains a key process for many conventional formulations.
Canaan focuses on application-specific equipment design to optimize the granulation process.
By customizing impeller angles, tip configurations and chopper designs, Canaan enhances material mixing and wet massing efficiency. These design considerations help promote more uniform granule formation and consistent granule properties, supporting improved tableting performance.
2. Moisture-Sensitive and Heat-Sensitive Materials → Dry Granulation
For materials that are sensitive to moisture or temperature, wet granulation may introduce additional processing risks.
Dry granulation is a suitable alternative because it does not require the addition of granulating liquids or a subsequent drying step. This makes it particularly suitable for formulations where moisture exposure and thermal processing need to be minimized.
By selecting an appropriate dry granulation process, manufacturers can better protect moisture- and heat-sensitive materials while maintaining process control.
3. Traditional Chinese Medicine Granules and High-Specification Formulations → One-Step Fluid Bed Granulation
When products require precise control over granule density and particle size distribution, one-step fluid bed granulation can offer significant process advantages.
Canaan applies one-step fluid bed granulation technology to different formulation requirements:
This approach supports more precise control of granule characteristics to meet demanding formulation and product quality requirements.
Compared with conventional granulation approaches, Canaan’s side-spray technology offers several potential process advantages:
Key Benefits of Canaan Side-Spray Granulation
Consistency in solid dosage manufacturing cannot be achieved by relying on the Tablet Press alone. It begins much earlier, with the selection of an appropriate granulation process.
Choosing the right granulation technology establishes a sound foundation for batch-to-batch consistency and reliable tablet production.
If your production line is experiencing batch variability or inconsistent tablet compression performance, Canaan process engineering team is ready to help.
Contact Canaan to discuss your material characteristics and evaluate the most suitable granulation process for your application.
Batch-to-batch variability and low tablet production yields remain persistent challenges in solid dosage manufacturing. When inconsistencies arise, manufacturers often focus on excipient selection or process parameter adjustments. In many cases, the underlying issue is in the selection of the granulation process itself. This article explores Canaan’s granulation solutions for different material characteristics and process requirements, […]
Quick Answer Continuous manufacturing pharmaceutical systems merge blending, granulation, and compression into one unbroken line to meet GMP compliance under 21 CFR Part 11. These lines run in-line, real-time quality monitoring instead of end-of-batch testing, typically handling 5 to 40 kg per hour. Canaan’s integrated pharmaceutical continuous manufacturing lines are built to meet these standards, […]
Quick Answer Cleaning validation in pharmaceutical manufacturing is the documented proof that equipment meets a set residue limit every time. A validated wash runs pre-rinse, detergent wash, rinse, and dry stages under fixed time, temperature, and pressure parameters. Canaan’s QD Series washing stations combine automated washing and drying in one controlled cycle, with key process […]
+86-577-67378828
canaan@chinacanaan.com